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Steve M. Blevins, MD,d Oklahoma City, Okla
Background: It is not clear whether subgroups of patients with peripheral artery disease (PAD) and claudication respond
more favorably to exercise rehabilitation than others. We determined whether sex and diabetes were factors associated
with the response to exercise rehabilitation in patients with claudication.
Methods: Eighty patients were randomized to home-based and supervised exercise programs, and 60 ﬁnished with
complete exercise intervention data. Exercise consisted of intermittent walking to near maximal claudication pain for
3 months. Primary outcome measures included claudication onset time (COT) and peak walking time. Patients were
partitioned into diabetic and nondiabetic groups and then further partitioned by sex to form four groups.
Results: Overall, exercise adherence was high (84%), and there was no signiﬁcant difference (P > .05) in the amount of
exercise completed among the four groups. All groups had signiﬁcant improvements (P < .05) in COT and peak walking
time after exercise rehabilitation, except for diabetic women (P > .05). Only 37% of women with diabetes had an increase
in COT compared with 100% of men with diabetes (P < .01), and their risk ratio for nonresponse was 9.2 (P < .0001).
Conclusions: Women with PAD and claudication, particularly those with diabetes, represent a vulnerable subgroup of
patients who respond poorly to a program of exercise rehabilitation. Diabetic women with PAD and claudication may
need a greater dose of exercise or another intervention separate from or in combination with exercise to elicit improve-
ments in claudication measures that are similar to nondiabetic women and to diabetic and nondiabetic men. (J Vasc Surg
2014;59:1036-43.)Peripheral artery disease (PAD) is prevalent in 8 million
Americans1 and is associated with high health economic
costs and high rates of morbidity and mortality similar to
coronary heart disease and ischemic stroke.2,3 Although
the prevalence of PAD in women is similar to men at all
ages, the burden of PAD, deﬁned as the total number of
individuals who have PAD, is greater in women.4 These
numbers are especially impressive given that women are
less likely to report symptoms than men,5 particularly those
characteristic of classic intermittent claudication.6 Once
becoming symptomatic, women have a twofold higher
mortality rate,7 a more functionally dependent lifestyle,5,8
shorter distances to the onset of claudication pain and tothe Reynolds Oklahoma Center on Aging, Donald W. Reynolds
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6maximal pain,9 and more impaired oxygen saturation of
the calf muscle during ambulation than men.10 More
severe impairments in claudication and in calf muscle
oxygen saturation in women with PAD may make them
particularly vulnerable for progressively worse lower
extremity function when these limitations are combined
with comorbid conditions that impair microcirculation,
such as diabetes.11,12
Supervised exercise programs are efﬁcacious for clinical
management of claudication13-16 and have been given a
class IA recommendation by the American College of
Cardiology and the American Heart Association.17
Although treatment of claudication with exercise rehabili-
tation is well documented, whether subgroups of PAD
patients respond more favorably than others is not clear.
For example, there is a paucity of data on the efﬁcacy of
exercise rehabilitation in women who have PAD and
claudication, because only a small percentage (27%) of
eligible patients in 32 previous randomized exercise trials
have been women.4 Furthermore, comparing sex-speciﬁc
responses to exercise has not been addressed. Diabetes is
another example in which there is conﬂicting and surpris-
ingly little data on the efﬁcacy of exercise rehabilitation.
One recent study found that claudication distances did
not improve in PAD patients with diabetes after 6 months
of exercise,18 whereas another recent report found that dia-
betic patients improved to a similar extent compared with
nondiabetic patients.19
To address the dearth of information on the potential
inﬂuences of sex and diabetes on responses to an exercise
program, we conducted a follow-up analysis to our recently
published20 prospective, randomized controlled exercise
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primary aim of the current study was to determine whether
sex and diabetes were factors associated with the response
to exercise rehabilitation in patients with claudication.
Secondary aims were to determine whether the amount
of exercise completed during intervention was different
according to sex and diabetes status, whether the amount
of exercise completed was associated with the change
scores of claudication onset time (COT) and peak walking
time (PWT), and to determine the characteristics of
patients who do not respond to exercise intervention.
Our primary hypothesis was that women would experience
less improvement in the primary outcome measures of
COT and PWT, that the presence of diabetes would blunt
the improvement in the primary outcomes, and that the
effect of diabetes would be greater in women than in men.
METHODS
The procedures used in this study were approved by
the University of Oklahoma Health Sciences Center
(HSC) Institutional Review Board.
Patients
Recruitment. Patients participated at the General
Clinical Research Center (GCRC), University of Okla-
homa Health Sciences Center (HSC) from September
2004 to April 2007. Patients were recruited by HSC
vascular clinic referrals and by newspaper advertisements.
Written informed consent was obtained from each patient
before investigation.
Screening. Patients who had claudication secondary to
vascular insufﬁciency were included if theymet the following
criteria: (1) a history of any type of exertional leg pain, (2)
ambulation during a graded treadmill test limited by leg
pain consistent with claudication,21 and (3) an ankle-
brachial index (ABI) #0.90 at rest17 or an ABI #0.73 after
exercise.22 Patients were excluded for the following condi-
tions: (1) absence of PAD (ABI>0.90 at rest andABI>0.73
after exercise), (2) inability to obtain an ABI measure due to
noncompressible vessels, (3) asymptomatic PAD deter-
mined from the medical history and veriﬁed during the
graded treadmill test, (4) use of cilostazol or pentoxifylline
initiated #3 months before investigation, (5) exercise
tolerance limited by any disease process other than PAD, (6)
active cancer, (7) end-stage renal disease deﬁned as stage 5
chronic kidney disease, (8) abnormal liver function, and (9)
randomization into the usual care control group.
As shown in our previous report,20 80 patients were
randomized to the home-based exercise program (n ¼ 40)
or to the supervised exercise program (n ¼ 40), and 60
patients completed both the exercise training programs
(n ¼ 29) and the post-tests (n ¼ 31). The remaining
20 patients were not included in our primary analyses
because 14 made personal decisions to discontinue, 4 were
medically excluded because of experiencing a stroke,
myocardial infarction, leg revascularization, and hernia
surgery during the study, and 2 were excluded because
they had incomplete exercise training data.Exercise interventions
Home-based exercise rehabilitation program. Exer-
cise sessions in our home-based exercise program were
rigorously quantiﬁed with a StepWatch3 step activity
monitor (Orthoinnovations Inc, Oklahoma City, Okla) to
accurately record the duration and cadence of ambulation.
The home-based exercise program was designed to be as
similar to the supervised exercise program as possible, and
we were indeed successful in matching the exercise volume
and exercise compliance of the two programs.20 The
home-based exercise program consisted of 3 months of
intermittent walking to near maximal claudication pain
3 days per week at a self-selected pace. Walking duration
began at 20 minutes for the ﬁrst 2 weeks and progressively
increased 5 minutes biweekly until a total of 45 minutes of
walking was accomplished during the ﬁnal 2 weeks of the
program.
Patients were given a step activity monitor and were
instructed to wear it on the right ankle during each exercise
session and then to remove the monitor at the completion
of each session. They also received an exercise logbook to
record their walking sessions. Patients returned their step
activity monitors and logbooks to the research staff at the
end of week 1, 2, 4, 6, 8, 10, and 12 of the program,
and data from the monitor were downloaded. During these
brief 15-minute meetings, patients discussed their progress
with an exercise physiologist, were given feedback about
the data from the step activity monitor, and were given
new instructions regarding changes in exercise duration.
Patients did not perform any exercise in our facility during
these meetings with the research staff.
Supervised exercise rehabilitation program. The
supervised program was designed to elicit increases in
COT and PWT according to our previous studies.13,20,23,24
This standardized program consisted of 3 months of
supervised, intermittent treadmill walking, 3 days per week
at a speed of approximately 2 mph. Walking duration
began at 15 minutes for the ﬁrst 2 weeks of the program,
and progressively increased by 5 minutes biweekly until
40 minutes of walking was accomplished during the ﬁnal
2 weeks of the program. Patients exercised at a relatively
low intensity by walking at a grade equal to 40% of the ﬁnal
workload from the baseline maximal treadmill test. Patients
walked to the point of near maximal claudication pain, at
which point they stopped to relieve their leg pain. Patients
then repeated the intermittent walking and rest periods
until the prescribed total number of minutes of exercise
was attained for the training session. During each exercise
session, patients wore a step activity monitor on the right
ankle to quantify the cadence and time of ambulation.
Patients in the supervised program were not given advice or
instructions to perform additional exercise away from our
research center.
Measurements
Medical history and physical examination. Patients
arrived in the morning fasted, but were permitted to take
Table I. Baseline clinical characteristics of 60 patients who completed 3 months of exercise rehabilitationa
Variables
Nondiabetic men
(n ¼ 19)
Nondiabetic women
(n ¼ 16)
Diabetic men
(n ¼ 9)
Diabetic women
(n ¼ 16)
Total group
(N ¼ 60)
Age, years 64 (14)b 74 (10) 64 (9) 60 (7) 66 (12)
Weight, kg 82.7 (17.5)b 70.7 (13.7) 107.2 (22.0)c 89.1 (13.1) 84.9 (19.7)
Body mass index, kg/m2 27.0 (4.7) 27.1 (5.3) 34.5 (7.5) 34.0 (5.2) 30.0 (6.4)
ABI 0.69 (0.22) 0.73 (0.21) 0.76 (0.20) 0.65 (0.29) 0.70 (0.23)
COT, seconds 235 (142) 156 (109) 257 (191) 163 (120) 198 (140)
PWT, seconds 464 (296) 300 (188) 409 (181) 278 (173) 362 (234)
Race, % Caucasian 63 75 44 25 47
Current smoking, % yes 0b 25 11 0 8
Hypertension, % yes 79 94 100 88 88
Dyslipidemia, % yes 89 88 89 100 92
Abdominal obesity, % yes 21 44 78 88 53
Metabolic syndrome components, No. 2.8 (1.0) 3.1 (1.2) 4.4 (1.0) 4.5 (0.6) 3.6 (1.2)
Metabolic syndrome, % yes 68 81 89 100 83
Obesity, % yes 21 31 78 81 48
ABI, Ankle-brachial index; COT, claudication onset time; PWT, peak walking time.
aValues are means (standard deviation) or percentage of patients.
bSigniﬁcantly different than the nondiabetic women (P < .05).
cSigniﬁcantly different than the diabetic women (P < .05).
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information, height, weight, cardiovascular risk factors,
comorbid conditions, claudication history, blood samples,
a list of current medications, and ABI were obtained
from a medical history and physical examination.
Gardner Maximal Treadmill Test. Patients per-
formed a progressive, graded treadmill protocol (2 mph,
0% grade with 2% increase every 2 minutes) until maximal
claudication pain on 2 separate days. The ﬁrst test was to
determine study eligibility by assessing whether exercise
performance was limited by claudication, whereas the
second test was done on another day to obtain the
outcome measures of COT and PWT. COT was deﬁned
as the walking time at which the patient ﬁrst experienced
pain, and PWT was deﬁned as the time at which ambula-
tion could not continue due to maximal pain. Using these
procedures, the test-retest intraclass reliability (R) coefﬁ-
cient in our laboratory is 0.89 for COT21 and 0.93 for
PWT.21
Statistical analyses
Patients were partitioned into diabetic and nondiabetic
groups and then further partitioned by sex under each cate-
gory to form four groups. Measurement variables were
summarized within each group by reporting mean, median,
and standard deviation. Dichotomous variables are re-
ported as percentage of participants with each attribute.
To avoid possible distortion of results due to departure
from normal distribution, wherever parametric and
nonparametric procedures were available, both were used
to test hypotheses for measurement variables. Differences
in pairs of groups were examined using the independent
t-test and corresponding Wilcoxon test. Differences among
groups in the exercise rehabilitation variables were exam-
ined using one-way analysis of variance and with the
Kruskal-Wallis nonparametric test.The DCOT, deﬁned as the change from baseline, was
calculated as the 3-month value minus the baseline value.
Patients with a positive DCOT were designated as
“responders.” The DCOT values within each group were
examined for difference from 0 using one-sample t-tests
and corresponding Wilcoxon tests. Responder rates were
tested using the two-sided sign test. Differences among
Dmeans of the four groups were examined using a two-
factor (sex, and diabetes) analysis of variance. Partial corre-
lations controlled for diabetes, sex, and interaction of
ﬁve exercise rehabilitation variables with DCOT were
computed. The exercise rehabilitation variable with the
largest correlation coefﬁcient was used as a covariate in
the analysis of covariance examination of DCOT means.
The DPWT was similarly obtained and analyzed. Selected
variables were examined as possible risk factors for failing
to become a responder for COT. All analyses were per-
formed using NCSS (Kaysville, Utah) statistical software.
Statistical signiﬁcance was set at P < .05.
RESULTS
Clinical characteristics. Patients with PAD were clas-
siﬁed into four groups by sex and diabetes status. The base-
line clinical characteristics of these groups are reported in
Table I. In patients without diabetes, men were signiﬁ-
cantly younger (P < .05) than women and had greater
body weight (P < .05) and lower prevalence of smoking
(P < .05). In patients with diabetes, men had greater body
weight (P < .05) than women.
Exercise intervention measures. The exercise inter-
vention measures of each group are reported in Table II.
There was no signiﬁcant difference among the four groups
for each variable. Overall, the exercise adherence was high
among the participants, as the mean percentage of exercise
sessions completed was 84%. Of particular interest, women
with diabetes were actually above average for adherence,
Table II. Exercise intervention measures
Variables
Nondiabetic men
(n ¼ 19),
mean (SD)
Nondiabetic women
(n ¼ 16),
mean (SD)
Diabetic men
(n ¼ 9),
mean (SD)
Diabetic women
(n ¼ 16),
mean (SD)
Total group
(N ¼ 60),
mean (SD)
Exercise sessions completed, % 92 (27) 76 (25) 74 (28) 87 (15) 84 (25)
Total exercise
Time, minutes 1135 (511) 877 (390) 1016 (606) 956 (476) 1001 (486)
Strides 49,702 (24,619) 35,664 (15,812) 40,632 (22,872) 37,374 (15,281) 41,310 (20,356)
Average exercise
Time, min/session 33.3 (11.3) 31.9 (13.1) 39.3 (30.4) 31.0 (17.1) 33.2 (17.0)
Strides, strides/session 1430 (407) 1285 (525) 1535 (814) 1195 (480) 1344 (533)
Cadence, strides/min 43.8 (6.5) 41.2 (7.7) 43.0 (9.1) 40.3 (11.9) 42.1 (8.8)
SD, Standard deviation.
Table III. Change scores for claudication onset time
(COT) (seconds) in peripheral artery disease (PAD)
patients with and without diabetes
Diabetes status Men Women Difference
No diabetes
Mean (SD) 189 (146)a 139 (191)b 50
Median 165a 49a 116
Diabetes
Mean (SD) 273 (212)a 52 (155) 221b
Median 294a 12 306b
All patients
Mean (SD) 216 (171)a 95 (177)a 121a
Median 169a 15b 154a
SD, Standard deviation.
Analysis of variance P values: sex effect ¼ .005, diabetes effect ¼ .982,
sex-by-diabetes interaction ¼ .069.
Analysis of covariance P values: sex effect ¼ .015, diabetes effect¼ .870, sex-
by-diabetes interaction ¼ 0.035, covariate (total exercise strides) ¼ .044.
Signiﬁcantly different than zero: aP < .01, bP < .05.
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an average exercise session, the entire group walked for
33 minutes at a cadence of 42 strides/min and took 1344
strides. There was no signiﬁcant difference among the four
sex/diabetes groups for the number of patients who did
not complete the study (P ¼ .332), and the difference
between the two exercise programs for noncompleters was
not signiﬁcant (P ¼ .606).
Primary outcome measures: Change scores for
COT and PWT. The change scores for COT in each
group are reported in Table III. All groups had signiﬁ-
cant improvements (P < .05) in mean and median COT
after exercise rehabilitation, except for diabetic women
(P > .05). Overall, there was a signiﬁcant sex effect for
mean COT change score (P ¼ .005), as men had a
121-second greater increase than women. Furthermore,
the sex by diabetes interaction for mean COT change score
was signiﬁcant after adjusting for total exercise strides taken
during the exercise rehabilitation program (P ¼ .035). This
is evident by noting that in patients with diabetes, the
increase in mean COT change score was 221 seconds
greater in men than in women (P < .05), whereas in thosewithout diabetes, the increase in COT change score was
only 50 seconds greater in men (P > .05). This ﬁnding is
further highlighted in Fig 1, which shows that only 37% of
women with diabetes had an increase in COT vs 100% of
men with diabetes (P < .01).
The change scores for PWT in each group are reported
in Table IV. All groups had signiﬁcant improvements (P <
.05) in mean and median PWT after exercise rehabilitation,
except for diabetic women (P > .05). Overall, there was
a signiﬁcant sex effect for the mean PWT change score
(P ¼ .003), as men had a 167-second greater increase than
women. There was a trend for a diabetes effect on the
mean PWT change score (P ¼ .056), as nondiabetic men
and women had larger increases than their diabetic counter-
parts. Similar to the COT results, the diabetic women had
the lowest percentage of responders to exercise, as only
56% had an increase in PWT (Fig 2). The sex-by-diabetes
interaction for mean PWT change score was not signiﬁcant
(P¼ .917), because the difference betweenmen andwomen
was similar in diabetic and nondiabetic patients.
The association between the exercise intervention
measures and the change scores for COT and PWT are re-
ported in Table V. The total number of strides accumu-
lated throughout the exercise program was associated
with the change score for COT (r ¼ 0.268; P ¼ .044),
as was the average number of strides taken per exercise
session (r ¼ 0.267; P ¼ .045). None of the other exercise
intervention measures was correlated with the changes
scores for COT or PWT.
Risk for nonresponse to exercise intervention. To
examine whether subsets of patients were more likely to
have a poor response to exercise rehabilitation, we calcu-
lated the risk ratio for nonresponse for each clinical charac-
teristic of the patients (Table VI). Forty percent of diabetic
patients did not respond to exercise rehabilitation, and
their risk ratio for nonresponse was 4.7 (P < .005)
compared with nondiabetic patients. Similarly, 41% of
women did not respond to exercise rehabilitation
compared with 0% of men (P < .0001). The presence of
diabetes in women was an especially poor combination,
because 63% did not respond to exercise and their risk ratio
for nonresponse was 9.2 (P < .0001). Twenty-six percent
Fig 1. Percentage of patients, stratiﬁed by sex and diabetes status,
whose change score for claudication onset time (COT) (ie,
responder) increased after exercise rehabilitation. Signiﬁcantly
different than zero: *P < .05; **P < .01.
Table IV. Change scores for peak walking time (PWT)
(seconds) in peripheral artery disease (PAD) patients with
and without diabetes
Diabetes status Men Women Difference
No diabetes
Mean (SD) 290 (200)a 144 (194)a 146b
Median 251a 89a 162b
Diabetes
Mean (SD) 198 (214)b 42 (128) 156b
Median 158b 4 154b
All patients
Mean (SD) 260 (206)a 93 (170)a 167a
Median 240a 25a 215a
SD, Standard deviation.
Analysis of variance P values: sex effect ¼ .003, diabetes effect ¼ .056,
sex-by-diabetes interaction ¼ 0.917.
Analysis of covariance P values: sex effect ¼ .005, diabetes effect ¼ .062,
sex-by-diabetes interaction¼ .900, covariate (total exercise strides)¼ 0.862.
Signiﬁcantly different than zero: aP < .01, bP < .05.
Table V. Exercise intervention measures and their
associations with the change scores for claudication onset
time (COT) and peak walking time (PWT)
Variables DCOT (r) DPWT (r)
Exercise sessions completed, % 0.178 0.062
Total exercise
Time, minutes 0.227 0.044
Strides 0.268a 0.023
Average exercise
Time, min/exercise session 0.193 0.032
Strides, strides/exercise session 0.267a 0.047
Cadence, strides/min 0.076 0.136
r, Pearson partial correlation coefﬁcients controlled for diabetes, sex, and
interaction.
aP < .05.
Fig 2. Percentage of patients, stratiﬁed by sex and diabetes status,
whose change score for peak walking time (PWT) (ie, responder)
increased after exercise rehabilitation. Signiﬁcantly different than
zero: *P < .05; **P < .01.
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exercise compared with 0% of those without metabolic
syndrome (P ¼ .099), but this trend was not as strong as
that found for diabetes. However, two of the components
of metabolic syndrome were more strongly related to poor
response to exercise rehabilitation, as the risk ratio for
nonresponse was 4.1 for elevated glucose (P ¼ .012)
and 2.9 for abdominal obesity (P ¼ .066). Finally, it
is important to note that poor response to exercise reha-
bilitation was not related (P ¼ .355) to whether the
intervention was performed in a supervised exercise or
home-based exercise setting.
DISCUSSION
Poor response to exercise in diabetic women. The
primary ﬁnding was that the only subgroup of patientswith PAD and claudication who did not signiﬁcantly
improve their COT and PWT after 3 months of exercise
rehabilitation was diabetic women. Of the two factors,
sex was more closely related to the exercise response than
diabetes, as the mean change scores for COT and PWT
in women were less than half of those in men, and fewer
women responded to exercise. This is the ﬁrst study to
directly compare the change scores of COT and PWT in
men and women. The impaired response in women
supports our hypothesis based on our previous base-
line ﬁndings examining differences between men and
women.9,10,25 Speciﬁcally, women with claudication have
shorter walking distances to the onset of claudication pain9
and to maximal claudication pain9,10 during standardized
treadmill exercise than men, even though their ABI is
similar.9,10 Furthermore, compared with men, women with
claudication have greater impairment in calf muscle
hemoglobin oxygen saturation during and after exercise,10
ambulate slower in the community setting, particularly for
Table VI. Percentages and risk ratio for nonresponse to
exercise intervention in patients with and without each
attribute
Attribute
Attribute
absent, %
Attribute
present, %
Risk ratio for
nonresponse P
Diabetes 8.6 40.0 4.7 .005
Female 0 40.6 . <.0001
Diabetic female 6.8 62.5 9.2 <.0001
Caucasian 25.0 18.8 0.8 .558
Current smoking 23.6 0.0 0 .344
Dyslipidemia 0.0 23.6 . .344
Elevated glucose 9.1 37.0 4.1 .012
Hypertension 28.6 20.8 0.7 .639
Abdominal obesity 10.7 31.3 2.9 .066
Metabolic
syndrome
0 26 . .099
Obesity 12.9 31.0 2.4 .121
Supervised exercise
program
27.6 16.1 0.6 .355
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daily ambulatory cadences correlate with poor calf muscle
hemoglobin oxygen saturation during exercise in
women.25 Collectively, these greater baseline limitations in
claudication, calf muscle hemoglobin oxygen saturation,
and daily ambulatory activity provided the basis of our
hypothesis that women would respond less favorably to
a program of exercise rehabilitation. However, the worse
response to exercise rehabilitation by women in the current
study was primarily found in those with diabetes, whereas
nondiabetic women had signiﬁcant improvements in COT
and PWT.
The coprevalence of diabetes in women with PAD and
claudication appears to be a particularly difﬁcult combina-
tion for treating claudication with an exercise program.
In a recent study examining PAD patients with diabetes,
of whom one-third were women, the walking distances
to onset of claudication pain and to maximal pain did not
change after 6 months of home-based exercise.18 These
ﬁndings suggest that diabetes interferes with the typical
exercise-mediated improvements in claudication measures
or that the home-based program was not efﬁcacious
because it relied on self-report for most of the exercise
sessions. Type 2 diabetes is associated with impaired micro-
vascular function in patients with PAD and claudication, as
reduced blood volume expansion12 and slower oxygen
kinetics11 occur in the calf musculature during exercise
compared with nondiabetic PAD patients. We have also
found that metabolic syndrome in patients with PAD,
which is considered a precursor to diabetes, worsens clau-
dication, physical function, health-related quality of life,
and peripheral circulation compared with patients without
metabolic syndrome26 and that abdominal obesity and
elevated fasting glucose are the components of metabolic
syndrome that are most predictive of these unfavorable
outcomes.27 Collectively, these ﬁndings support the results
of the current study, which found that diabetic women donot respond well to an exercise program designed to treat
claudication. However, some controversy exists regarding
the effect that diabetes has on ambulation in patients
with PAD, because a recent report found that 6 months
of supervised exercise increased the walking distances to
onset of pain and to maximal pain in diabetic patients
with PAD and that their response was not different than
patients without diabetes.19
Quantiﬁed exercise rehabilitation stimulus and
characteristics of nonresponders. A strength of the
current investigation was that the exercise time, cadence,
and ambulatory volume completed during the exercise
programs were directly quantiﬁed with a step activity
monitor worn around the ankle during each exercise
session. Until our recent trial,20 no other randomized
controlled exercise trial reported the exercise volume per-
formed during the program. In the present study, none of
the exercise rehabilitation measures were different among
the four groups, and adherence to exercise was high in each
group. Speciﬁcally, the diabetic women completed 87% of
their exercise sessions, and during an average session, they
walked for 31 minutes at a cadence of 40 strides/min and
took 1195 strides. Thus, performing less exercise than the
other groups can be ruled out as a reason why the diabetic
women had smaller change scores for COT and PWT than
the other groups.
Another important ﬁnding was that the total number
of strides taken during the program and the average
number of strides taken during each session were both
positively correlated with the change score in COT, sug-
gesting that more ambulatory strides completed during
intervention was associated with delaying the onset of clau-
dication. Collectively, these ﬁndings suggest that diabetic
women with PAD may need to complete a higher volume
of exercise to demonstrate efﬁcacy than other groups of
PAD patients.
Examination of whether clinical characteristics are
predictive of nonresponse to exercise provides important
information when considering an exercise intervention to
treat claudication in PAD patients. As was found for the
group analyses, female sex and diabetes were signiﬁcantly
associated with nonresponse to exercise, and having both
characteristics was most signiﬁcant by far. Interestingly,
racial composition, current smoking status, and whether
exercise was performed in a home-based program or
a supervised program were not associated with non-
response to exercise. Thus, many patients can beneﬁt
from an exercise program, regardless of whether the setting
is home-based or an on-site supervised program. We have
previously shown that smokers and nonsmokers both
improve COT and PWT after an exercise rehabilitation
program24 and that home-based and supervised exercise
programs are efﬁcacious,20 both of which support our
current ﬁndings. Although metabolic syndrome and its
individual components were not signiﬁcantly associated
with lack of response to exercise, there were trends in
that direction. For example, those with abdominal obesity
had a risk ratio of 2.9 for nonresponse, suggesting that they
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of exercise than patients without abdominal obesity.
Limitations. Although the exercise rehabilitation
programs were efﬁcacious for increasing COT and PWT,
several limitations exist. First, patients who participated in
this trial were volunteers and therefore may represent those
more interested in exercise, those who had better access to
transportation to our research facilities, and those in rela-
tively better health than patients who did not volunteer.
Second, although 85% of the patients had a history of
smoking as former smokers, our sample consisted of a rela-
tively low percentage of current smokers.
Third, to address whether sex, diabetes, and other clin-
ical factors were related to the response to exercise, it was
necessary to limit the analyses to only those who completed
exercise rehabilitation. Previously, we found no difference in
baseline characteristics between patients who completed
this trial and patients who did not complete the study,
and no differences were found between the observed data
on those patients who completed the trial compared with
intent-to-treat analyses using imputed data on all patients.20
It is possible that those who withdrew would have been
poor responders to exercise if they had completed the study.
However, there was no signiﬁcant difference among the
four groups for the number of dropouts, indicating that
dropouts did not bias our current results.
Finally, because women were shorter than men on
average, they may have needed to ambulate at a slightly
faster cadence during the treadmill test. However, since
this would be true for both the pretest and the post-test
condition, we do not believe that sex difference in cadence
during the treadmill test had an inﬂuence on the change
scores for COT and PWT.
CONCLUSIONS
Our primary novel ﬁnding was that women had smaller
change scores in COT and PWT after 3 months of exercise
rehabilitation than men, primarily due to the negative inﬂu-
ence of diabetes, as only 37% of diabetic women increased
their COT. This poor response occurred despite diabetic
women having comparable values to other patients in exer-
cise compliance and in the amount of exercise accom-
plished during the rehabilitation program. We conclude
that women with PAD and claudication, particularly those
with diabetes, represent a vulnerable subgroup of patients
who respond poorly to a program of exercise rehabilitation.
The clinical implication is that diabetic women with PAD
and claudication may need a greater dose of exercise or
another intervention separate from or in combination
with exercise to elicit improvements in claudication
measures that are similar to nondiabetic women and to dia-
betic and nondiabetic men.
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